Trends in Ezetimibe Prescriptions as Monotherapy or Fixed-Dose Combination in Germany 2012–2021

AIMS: Addition of ezetimibe to statin therapy is recommended by current guidelines when low-density lipoprotein cholesterol (LDL-C) targets are not achieved with statin monotherapy. Fixed-dose combinations (FDC) improve medication adherence and facilitate risk factor control. We assessed prescriptio...

Descripción completa

Detalles Bibliográficos
Autores principales: Katzmann, Julius L., Kieble, Marita, Enners, Salka, Böhm, Michael, Mahfoud, Felix, Laufs, Ulrich, Schulz, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234160/
https://www.ncbi.nlm.nih.gov/pubmed/35770230
http://dx.doi.org/10.3389/fcvm.2022.912785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234160/
https://www.ncbi.nlm.nih.gov/pubmed/35770230
http://dx.doi.org/10.3389/fcvm.2022.912785

Ejemplares similares